Atlas Trials

Safety and Treatment Satisfaction in Adults With Chronic ITP After Switching to Avatrombopag From Eltrombopag or Romiplostim

Clinical trial NCT04638829 · COMPLETED

Trial details

NCT number
NCT04638829
Sponsor
Sobi, Inc.
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Immune Thrombocytopenia
Start date
2021-03-15
Primary completion
2024-01-03
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.